Ganciclovir

"Ganciclovir" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

An ACYCLOVIR analog that is a potent inhibitor of the Herpesvirus family including cytomegalovirus. Ganciclovir is used to treat complications from AIDS-associated cytomegalovirus infections.

Descriptor ID

D015774

MeSH Number(s)

D03.438.759.758.399.454.250.300

Concept/Terms

Ganciclovir, Monosodium Salt

BIOLF-62

Cytovene

Below are MeSH descriptors whose meaning is more general than "Ganciclovir".

Chemicals and Drugs [D]
Heterocyclic Compounds [D03]
Heterocyclic Compounds, 2-Ring [D03.438]
Purines [D03.438.759]
Purinones [D03.438.759.758]
Hypoxanthines [D03.438.759.758.399]
Guanine [D03.438.759.758.399.454]
Acyclovir [D03.438.759.758.399.454.250]
Ganciclovir [D03.438.759.758.399.454.250.300]

Below are MeSH descriptors whose meaning is related to "Ganciclovir".

Below are MeSH descriptors whose meaning is more specific than "Ganciclovir".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Ganciclovir" by people in Harvard Catalyst Profiles by year, and whether "Ganciclovir" was a major or minor topic of these publication.

Bar chart showing 162 publications over 29 distinct years, with a maximum of 14 publications in 2000

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1993	3	2	5
1994	4	6	10
1995	5	1	6
1996	8	3	11
1997	6	4	10
1998	8	4	12
1999	2	7	9
2000	8	6	14
2001	5	8	13
2002	4	4	8
2003	2	3	5
2004	2	5	7
2005	1	1	2
2006	2	3	5
2007	0	5	5
2008	1	1	2
2009	2	3	5
2010	0	1	1
2011	0	1	1
2012	0	2	2
2013	1	8	9
2014	2	2	4
2015	1	0	1
2016	1	3	4
2017	1	1	2
2018	1	1	2
2019	1	2	3
2020	0	1	1
2022	0	3	3

Below are the most recent publications written about "Ganciclovir" by people in Profiles.

Drug Resistance Mutations and Associated Phenotypes Detected in Clinical Trials of Maribavir for Treatment of Cytomegalovirus Infection. J Infect Dis. 2022 09 04; 226(4):576-584.

View in: PubMed
Cytomegalovirus infection in transplant recipients: newly approved additions to our armamentarium. Clin Microbiol Infect. 2023 Jan; 29(1):44-50.

View in: PubMed
Synthetic introns enable splicing factor mutation-dependent targeting of cancer cells. Nat Biotechnol. 2022 07; 40(7):1103-1113.

View in: PubMed
PET Reporter Gene Imaging and Ganciclovir-Mediated Ablation of Chimeric Antigen Receptor T Cells in Solid Tumors. Cancer Res. 2020 11 01; 80(21):4731-4740.

View in: PubMed
Primary cytomegalovirus infection with invasive disease in a patient with inflammatory bowel disease. BMJ Case Rep. 2019 Sep 30; 12(9).

View in: PubMed
Targeted AAVP-based therapy in a mouse model of human glioblastoma: a comparison of cytotoxic versus suicide gene delivery strategies. Cancer Gene Ther. 2020 05; 27(5):301-310.

View in: PubMed
Pediatric post-transplant hepatic kaposi sarcoma due to donor-derived human herpesvirus 8. Pediatr Transplant. 2019 05; 23(3):e13384.

View in: PubMed
Cytomegalovirus meningitis in a patient with relapsed acute myeloid leukemia. Int J Hematol. 2019 Feb; 109(2):233-238.

View in: PubMed
Molecular ablation of tumor blood vessels inhibits therapeutic effects of radiation and bevacizumab. Neuro Oncol. 2018 09 03; 20(10):1356-1367.

View in: PubMed
Low-dose valganciclovir for cytomegalovirus prophylaxis in intermediate-risk liver transplantation recipients. Liver Transpl. 2018 05; 24(5):616-622.

View in: PubMed

Related Networks

People

Explore

Similar Concepts

Top Journals

Transplantation
Transpl Infect Dis
Antimicrob Agents Chemother
J Infect Dis
Hum Gene Ther
Cancer Res
Cancer Gene Ther
Am J Ophthalmol
Am J Transplant
Transplant Proc